Search

everythinglearnresearchcommunity

for

Search:↓

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Blocking certain fat production can reverse skin inflammation and hair loss.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Topical mitotic blocking agents like colchicine can be dangerous and potentially fatal, and hair loss from rapid weight loss is due to low protein, not the speed of weight loss.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Gene expression in hair follicles can help diagnose methamphetamine use disorder.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Clofazimine effectively treated ashy dermatosis in a patient.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Drugs that block GSK-3 show promise for treating various diseases.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

New inhibitors may reduce gut toxicity from cancer drugs.

Methotrexate is generally safe and often effective for treating hair loss in children.

The treatment was not recommended due to limited effectiveness and significant side effects.